12 Health Care Stocks Moving In Thursday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Thursday's intraday session, several healthcare stocks experienced significant movements. NeuroBo Pharmaceuticals (NRBO) led the gainers with a 55.3% increase, while Revelation Biosciences (REVB) saw the largest decrease among the losers, dropping 62.6%. Other notable movers included Kiora Pharmaceuticals (KPRX) and Celularity (CELU) with substantial gains, and InVivo Therapeutics Holdings (NVIV) and Bullfrog AI Holdings (BFRG) with notable losses.
February 01, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bullfrog AI Holdings shares decreased by 23.16% to $3.75, with a market value of $22.8 million.
The drop in BFRG's stock price may be due to adverse developments or investor reactions, indicating a short-term negative impact on its stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
InVivo Therapeutics Holdings stock decreased by 45.64% to $0.35, with a market cap of $1.0 million.
NVIV's significant stock price decrease could reflect negative market news or internal issues, suggesting a short-term negative impact on its stock price.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Revelation Biosciences stock plummeted 62.6% to $3.29.
The significant drop in REVB's stock price could be due to negative news or poor financial performance, suggesting a short-term negative impact on its stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Celularity shares rose 29.97% to $0.49, with a market cap of $106.2 million.
The increase in CELU's stock price indicates positive market reception or internal company progress, suggesting a short-term positive impact on its stock price.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Kiora Pharmaceuticals shares increased by 48.24% to $0.82, with a market cap of $6.2 million.
KPRX's significant stock price increase suggests positive investor sentiment or favorable company developments, likely leading to a short-term positive impact on its stock price.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
NeuroBo Pharmaceuticals stock surged 55.3% to $5.08, with a market cap of $24.6 million.
The substantial increase in NRBO's stock price indicates strong investor interest or positive developments within the company, likely leading to a short-term positive impact on its stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100